This prospective randomized controlled trial aimed to evaluate the efficacy and safety of Fu' s Subcutaneous Needling (FSN) for residual pain in patients with osteoporotic vertebral compression fractures (OVCFs) after percutaneous vertebroplasty (PVP). Fifty patients with residual low back pain occurring after PVP in the Department of Orthopedics of Bazhong City Hospital of Traditional Chinese Medicine were prospectively included, and were divided into the control group and the FSN group according to the randomized numerical table method, with 25 patients in each group. The control group received oral alfacalcidol, calcium carbonate, and alendronate in accordance with the 2022 Chinese Guidelines for Primary Osteoporosis. In addition to these treatments, the FSN group received FSN. Outcome measures, including Visual Analog Scale (VAS), Oswestry Disability Index (ODI), and Modified Japanese Orthopedic Association (M-JOA) scores, were assessed at baseline (t0), immediately post-intervention (t1), and at multiple follow-up time points: 2 days (t2), 3 days (t3), 4 days (t4), 1 week (t5), 1 month (t6), and 3 months (t7) post-intervention. Compared with the control group, the FSN group demonstrated significantly higher total efficacy (68.0% vs. 95.8%, P < 0.05), lower VAS scores at t1–t3, t5–t6 (P < 0.05), and improved ODI and M-JOA scores (P < 0.05). FSN alleviates residual post-PVP pain, enhances functional recovery, and improves quality of life.

Cheng Long, Zhao Shuchuan, Shi Xin, Ma Qiang, Feng Xi, Wang Jing, Li Jiangjiang, Cui Jianhua. Observation of the Therapeutic Effect of Fu's Subcutaneous Needling on Residual Lower Back Pain in Elderly Patients after PVP Surgery. Academic Journal of Medicine & Health Sciences(2025), Vol. 6, Issue 3: 1-7. https://doi.org/10.25236/AJMHS.2025.060301.

[1] Guidelines for the diagnosis and treatment of primary osteoporosis (2022)[J]. Chinese Journal of Osteoporosis and Bone Mineral Salt Diseases,2022,15(06):573-611.

[2] Luthman S, Widén J, Borgström F. Appropriateness criteria for treatment of osteoporotic vertebral compression fractures)[J]. Osteoporos Int. 2018;29(4):793-804.

[3] Hinde K, Maingard J, Hirsch J A, et al. Mortality Outcomes of Vertebral Augmentation (Vertebroplasty and/or Balloon Kyphoplasty) for Osteoporotic Vertebral Compression Fractures: A Systematic Review and Meta-Analysis)[J]. Radiology. 2020;295(1):96-103.

[4] Rabei R, Patel K, Ginsburg M, et al. Percutaneous Vertebral Augmentation for Vertebral Compression Fractures: National Trends in the Medicare Population (2005-2015))[J]. Spine (Phila Pa 1976). 2019;44(2):123-133.

[5] Li Q, Shi L, Wang Y, et al. A Nomogram for Predicting the Residual Back Pain after Percutaneous Vertebroplasty for Osteoporotic Vertebral Compression Fractures)[J]. Pain Res Manag. 2021; 2021:3624614.

[6] Yuan W J, Xu P A, Liang Z, et al. Effect of ketorolac on postoperative analgesic effect and safety analysis of patients undergoing percutaneous transluminal vertebroplasty[J]. Chinese Pharmacist, 2023,26(12):449-455.

[7] Shao Y J, Xie H L, Wang X C, et al. A randomized controlled study of floating needle therapy for chronic non-specific lower back pain[J]. Hubei Journal of Traditional Chinese Medicine, 2021,43(07):45-48.

[8] Hu K X. Effect of floating needle in treating residual pain after PVP for osteoporotic vertebral compression fracture[J]. Chinese and foreign medicine research,2021,19(03):45-47.

[9] Yu Y A, Wang Z G, Mao T, et al. Floating needle treatment of residual pain after percutaneous vertebroplasty in 30 cases[J]. Chinese Journal of Orthopedics and Traumatology,2021,29(09):74-76+80.

[10] Cheng J W, Wang Z L,Liu W, et al. Improvement of Oswestry dysfunction index and reliability and validity test[J]. Chinese Spinal Cord Journal,2017,27(03):235-241.

[11] Yan H M, Jiang Y, Hu L H, et al. Key issues in the design of efficacy indexes for clinical trials of symptomatic new Chinese medicines[J]. Drug Evaluation Research,2023,46(09):1833-1840.

[12] Shen F, Li W, Ye B S, et al. Progress of rehabilitation of chronic pain after osteoporotic vertebral compression fracture kyphoplasty[J]. Chinese Journal of Orthopedics and Traumatology, 2024, 32(07):91-96.

[13] Huang W T, Wan S M, Wang Z G, et al. Progress of Chinese and Western medicine treatment of residual low back pain after percutaneous vertebroplasty[J]. Journal of Jiangxi University of Traditional Chinese Medicine,2024,36(03):115-119+123.

[14] Yang J X, Fu Z H. Analyzing the theory and clinical research of floating needle[J]. Western Chinese medicine,2015,28(06):156-158.

[15] Peng Y J, Zhu B M, Wu X. Acupuncture depth and systems biology[J]. World Science and Technology-Modernization of Traditional Chinese Medicine,2019,21(03):444-448.

[16] Fu Z H. Reperfusion and reperfusion activity - on the method of activity while treating in external treatment[J]. Chinese Acupuncture and Moxibustion,2015,35(S1):68-71.

[17] Liu N, Fu Z H, He Q T, et al. Introduction to floating needle reperfusion activity[J]. Chinese medicine introduction,2018,24(23):93-95.

[18] Tao J L, Fu Z H, Zhang H R. Analysis of the action mechanism of floating needle therapy[J]. Shizhen Guomian Guomian,2014,25(12):3006-3008.